Insider Ledger
Cardiff Oncology, Inc. (CRDF) insider buying and SEC filings
Cardiff Oncology, Inc. · CIK 1213037
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- Trovagene, Inc.; TrovaGene Inc.; XENOMICS INC; USED KAR PARTS INC
Insider activity in the last 12 months
Bought
$1.1M
Insiders who bought
2
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jul 14, 2026 | Other purchase | Gary W. Pace (Director) bought 687,285 Common Stock Purchase Warrant at $0.0000 ($0), reported as a purchase (code P). New position of 687,285 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 16, 2026 |
| Jul 14, 2026 | Purchase (code P) | Gary W. Pace (Director) bought 687,285 shares at $1.46 ($1.0M), reported as a purchase (code P). Holdings up 51% to 2,043,661 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 16, 2026 |
| Jul 14, 2026 | Other purchase | Mani Mohindru (CEO and Director) bought 34,364 Common Stock Purchase Warrant at $0.0000 ($0), reported as a purchase (code P). New position of 34,364 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 16, 2026 |
| Jul 14, 2026 | Purchase (code P) | Mani Mohindru (CEO and Director) bought 34,364 shares at $1.46 ($50K), reported as a purchase (code P). Holdings up 139% to 59,067 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 16, 2026 |
| Jun 18, 2026 | Purchase (code P) | Mani Mohindru (CEO and Director) bought 24,703 shares at $1.21 ($30K), reported as a purchase (code P). New position of 24,703 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 22, 2026 |
| Jun 18, 2026 | Purchase (code P) | Gary W. Pace (Director) bought 30,000 shares at $1.22 ($37K), reported as a purchase (code P). Holdings up 2% to 1,356,376 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 22, 2026 |
11 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
2 insiders bought in 30 days
$1.1M in purchases since Jun 18, 2026 · Purchases traded Jun 18, 2026 to Jul 14, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Gary W. Pace (Director) | $37K | Jun 18, 2026 | SEC filing |
| Mani Mohindru (CEO) | $30K | Jun 18, 2026 | SEC filing |
| Mani Mohindru (CEO) | $50K | Jul 14, 2026 | SEC filing |
| Gary W. Pace (Director) | $1.0M | Jul 14, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow CRDF in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.